This is exactly the hostage taking the American people will witness for the next two years. Congress is again attempting intimidation of President Obama for their extremist agenda.
The USA is not bankrupt and while there are no current patients suffering from Ebola in the USA the AGREED strategy to fight the disease in it's place of origin protects Americans.
The vaccine is real and promising and it's further perfection needs to be funded.
U.S. President Barack Obama speaks next to Ebola response coordinator Ron Klain (L) as he hosts a meeting with his Ebola response team in the Roosevelt Room of the White House in Washington, November 18, 2014.(Reuters) - President Barack Obama (click here) on Tuesday will press Congress to approve $6.18 billion in emergency funding to help fight the Ebola outbreak in West Africa and prepare U.S. hospitals to handle future cases.
Most of the request is aimed at the immediate response to the disease at home and abroad. But the package also includes $1.5 billion in contingency funds - money that could become a target if lawmakers decide to trim the bill.
"That is the part of the package that is most at risk," said Sam Worthington, president of InterAction, an alliance of U.S. non-governmental aid groups.
While lawmakers recognize that the United States had to take action to arrest the deadly disease, some are wary of giving the administration leeway in investing money in public health systems in West Africa....
S. 1569: Default Prevention Act of 2013 is on the agenda today in the US Senate. There should be an amendment to it which provides the funding needed to complete the work on Ebola.
November 29, 2014
By Luther Turmelle
Protein Sciences (click here) is making a name for itself in a pharmaceutical industry that is filled with high profile, international competitors.
By Luther Turmelle
Protein Sciences (click here) is making a name for itself in a pharmaceutical industry that is filled with high profile, international competitors.
Merck, Bristol-Myers Squibb and Pfizer are names that are probably more recognizable to the average consumer. But Meriden-based Protein Sciences, which has been in business for 31 years, has been capturing the public’s attention lately for one of its vaccines that is already available and another that is in development.
The one that is in development, which prevents the spread of the Ebola virus, got the most attention in October when Americans’ fear of catching the disease, which has killed thousands in Africa, was at its height....
...Protein Sciences expects to submit its Ebola vaccine to the National Institutes of Health (NIH) by the end of the year. Once that happens, NIH researchers will conduct animal testing of the vaccine on monkeys, which will the be exposed to the Ebola virus.
Even as it is moving to develop a way to prevent Ebola, Protein Sciences is looking to expand awareness of its influenza vaccine, Flublok. The vaccine made its debut in November of last year and sold only 30,000 doses, which Manon Cox, Protein Sciences’ president and chief executive officer, said is less than one percent of the total market.
The company is hoping to expand upon that this flu season, boosted by last month’s decision by the U.S. Food and Drug Administration to allow Flublok to be administered to individuals 50 years of age and older. The vaccine has a distinct advantage over its competition in the marketplace, made by companies like GlaxoSmithKline, Sanofi and AstraZeneca: Protein Sciences’ product is not made with chicken eggs....
Dr. Fauci is leading the efforts to achieve the vaccine. He is more than qualified to ask for the funding. His own professional profile includes acting as an immunologist who has made substantial contributions to HIV/AIDS research and other immunodeficiencies. This is not a shoot from the hip effort. These are highly qualified research scientists that now need to move the vaccine to clinical trials as required by law in order to manufacture the vaccine for use in humans.
October 20, 2014
By Jon Cohen
...Geisbert told Science Insider (click here) he “completely” agrees with Fauci’s assessment. “His comment is spot on,” Geisbert says. “The smaller companies that were working on Ebola vaccines and treatments did not have the financial resources” to make the clinical grade product needed to stage human studies. NIH funding typically supports research, not product development....
The delay in legislative support to the USA's best interests will be common during the next two years. The US House sincerely has no interest in understanding the needs of the country, even emergent needs such as the Ebola vaccine. If this trend in legislation continues it is valid to say the Republican Congress is profoundly incompetent.
President Obama needs to realize he is getting a rather incompetent bunch in January. His strategy to accomplish the country's goals should be made public before the State of the Union which is the best place to move Congress to act.
The US House doesn't have leadership. It has a group of legislators with the enforcement of the Hastert Rule cripples the legislative process. There is no appreciation for emergent needs of the country. The US House slices and dices legislation to JUST UNDERSTAND the issues and micromanage the monies appropriated. This Congress coming in will have more of the same and not less. Basically, the legislative process in the USA is compromised.
Ebola Diagnostics Research (click here)
NIAID is also supporting the development of improved diagnostics for Ebolavirus infection. For example, NIAID is funding a Lassa fever recombinant antigen diagnostic. A similar diagnostic is being designed to detect Ebolavirus infection. NIAID also is supporting development of multiplex diagnostics, microfluidics-based diagnostics and optofluidic-based diagnostics for Ebola.
US Congress finds it convenient to blame President Obama for their own failings. The lawsuit the Speaker brought could easily be solved with legislation that provides workable solutions to small business owners, but, that hasn't happened because it is politically advantageous to hold President Obama hostage.
The entire circumstances with Congress is hideous. They play politics when in fact the answer to the problems they complain about is within the power of the legislature to solve. It's a stalemate that is more characteristic of a bloodless coup.
The entire circumstances with Congress is hideous. They play politics when in fact the answer to the problems they complain about is within the power of the legislature to solve. It's a stalemate that is more characteristic of a bloodless coup.
